RPMMX
Price
$18.73
Change
-$0.13 (-0.69%)
Updated
Sep 20 closing price
VMVAX
Price
$86.17
Change
-$0.37 (-0.43%)
Updated
Sep 20 closing price
Ad is loading...

RPMMX vs VMVAX

Header iconRPMMX vs VMVAX Comparison
Open Charts RPMMX vs VMVAXBanner chart's image
Reinhart Mid Cap PMV I
Price$18.73
Change-$0.13 (-0.69%)
VolumeN/A
CapitalizationN/A
Vanguard Mid-Cap Value Index Admiral
Price$86.17
Change-$0.37 (-0.43%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
RPMMX vs VMVAX Comparison Chart
Loading...
VS
RPMMX vs. VMVAX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RPMMX is a Buy and VMVAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 30.5B vs. RPMMX (132M). VMVAX pays higher dividends than RPMMX: VMVAX (2.14) vs RPMMX (0.69). RPMMX was incepted earlier than VMVAX: RPMMX (12 years) vs VMVAX (13 years). RPMMX is a more actively managed with annual turnover of: 42.00 vs. VMVAX (22.00). VMVAX has a lower initial minimum investment than RPMMX: VMVAX (3000) vs RPMMX (5000). VMVAX annual gain was more profitable for investors over the last year : 25.35 vs. RPMMX (16.12). VMVAX return over 5 years is better than : 48.82 vs. RPMMX (31.21).
RPMMXVMVAXRPMMX / VMVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence12 years13 years-
Gain YTD11.88814.94680%
Front LoadN/AN/A-
Min. Initial Investment50003000167%
Min. Initial Investment IRAN/AN/A-
Net Assets132M30.5B0%
Annual Yield % from dividends0.692.1432%
Returns for 1 year16.1225.3564%
Returns for 3 years8.4020.7141%
Returns for 5 years31.2148.8264%
Returns for 10 years34.56100.8834%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AUUD0.790.01
+0.67%
Auddia
CTLT60.00-0.11
-0.18%
CATALENT
JAMF18.49-0.09
-0.48%
Jamf Holding Corp
ARCT20.61-0.41
-1.95%
Arcturus Therapeutics Holdings
ANVS8.47-0.17
-1.97%
Annovis Bio